Composition
- Active ingredients
- BETAMETHASONE DIPROPIONATE 0.064%; CALCIPOTRIENE 0.005%
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA212367.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Calcipotriene and Bethamethasone Dipropionate
- Active substance
- betamethasone dipropionate
- Route
- Topical
- Dosage form
- Suspension
- Applicant
- Padagis Israel
- Status
- Discontinued
- FDA approval
- 11 Sept 2020
- Application
- ANDA212367-001